TY  - GENERIC
DO  - 10.20944/preprints202407.0864.v1
UR  - http://dx.doi.org/10.20944/preprints202407.0864.v1
TI  - Anti-HER2 cancer-specific mAb, H2Mab-250-hG<sub>1</sub> possesses higher complement-dependent cytotoxicity than trastuzumab
T2  - Preprints
AU  - Suzuki, Hiroyuki
AU  - Ohishi, Tomokazu
AU  - Tanaka, Tomohiro
AU  - Kaneko, Mika K.
AU  - Kato, Yukinari
PY  - 2024
DA  - 2024/07/11
PB  - Preprints